150,000 Shares in Albemarle Corporation $ALB Purchased by Bornite Capital Management LP

Bornite Capital Management LP acquired a new stake in Albemarle Corporation (NYSE:ALB – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 150,000 shares of the specialty chemicals company’s stock, valued at approximately $15,867,000. Albemarle comprises about 2.3% of Bornite Capital Management LP’s holdings, making the stock its 20th biggest holding. Bornite Capital Management LP owned approximately 0.13% of Albemarle as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Primecap Management Co. CA bought a new position in shares of Albemarle in the 2nd quarter valued at about $358,101,000. Deutsche Bank AG bought a new stake in shares of Albemarle in the 2nd quarter valued at about $131,049,000. Bank of New York Mellon Corp bought a new stake in shares of Albemarle in the 2nd quarter valued at about $103,268,000. Aberdeen Group plc raised its holdings in shares of Albemarle by 5,344.0% in the 3rd quarter. Aberdeen Group plc now owns 753,618 shares of the specialty chemicals company’s stock valued at $79,718,000 after purchasing an additional 739,775 shares during the period. Finally, Robeco Institutional Asset Management B.V. lifted its stake in Albemarle by 2,981.1% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 733,793 shares of the specialty chemicals company’s stock valued at $77,621,000 after purchasing an additional 709,977 shares during the last quarter. 92.87% of the stock is owned by institutional investors.

Albemarle Stock Performance

Shares of ALB stock opened at $85.64 on Thursday. The company has a market capitalization of $10.11 billion, a price-to-earnings ratio of 20.69, a PEG ratio of 0.55 and a beta of 1.34. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 2.34. The company has a 50-day simple moving average of $101.19 and a 200 day simple moving average of $144.19. Albemarle Corporation has a 52 week low of $85.22 and a 52 week high of $221.00.

Albemarle (NYSE:ALB – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.05. The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.52 billion. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. Albemarle’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.19) EPS. On average, sell-side analysts predict that Albemarle Corporation will post 10.64 earnings per share for the current year.

Albemarle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be issued a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Friday, December 18th. Albemarle’s payout ratio is currently 39.61%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Robert W. Baird reduced their price target on Albemarle from $157.00 to $123.00 in a report on Wednesday, October 14th. Truist Financial restated a “buy” rating and issued a $170.00 price objective (down from $185.00) on shares of Albemarle in a research note on Friday, November 6th. Scotiabank cut their price objective on Albemarle from $190.00 to $165.00 and set a “sector outperform” rating for the company in a research report on Monday, November 9th. Argus reduced their target price on Albemarle from $230.00 to $135.00 and set a “buy” rating for the company in a research note on Wednesday, October 7th. Finally, Zacks Research upgraded Albemarle from a “strong sell” rating to a “hold” rating in a research note on Monday, November 9th. Fifteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $152.63.

Read Our Latest Research Report on ALB

About Albemarle

(Free Report)

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.

Featured Stories

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.